Oral Micronized Progesterone Cost in Maine (2026)

Prescription access and medication affordability image for Oral Micronized Progesterone Cost in Maine (2026)

How Much Does Oral Micronized Progesterone Cost in Maine?

At a glance

  • Generic oral micronized progesterone / $45 per month average cash price in Maine (2026)
  • Brand Prometrium / $180 per month manufacturer list price
  • Compounded progesterone (503A pharmacy) / approximately $25 per month
  • Maine Medicaid / covered with prior authorization
  • Dosing schedule / nightly continuous or cyclic (12 to 14 days per month)
  • Dose form / oral capsule (100 mg or 200 mg)
  • Telehealth prescribing / legal in Maine
  • 503A compounding / permitted in Maine
  • FDA-approved indication / endometrial protection in postmenopausal women on estrogen

Maine Retail Pharmacy Pricing in 2026

The average cash price for generic oral micronized progesterone across Maine retail pharmacies sits at $45 per month in 2026. That figure reflects the standard 100 mg or 200 mg capsule dispensed for a 30-day supply at chain and independent pharmacies statewide.

Brand-name Prometrium, originally developed by Solvay and now marketed by AbbVie, carries a manufacturer list price of $180 per month. Few patients pay this full amount. The spread between brand and generic pricing exists because multiple generic manufacturers (including Teva, Mylan, and Sun Pharmaceutical) entered the market after Prometrium's patent expiration. The PEPI trial (N=875) established oral micronized progesterone as the standard for endometrial protection in women receiving estrogen therapy, demonstrating equivalent endometrial safety to medroxyprogesterone acetate with a more favorable lipid profile 1. This trial drove broad formulary inclusion and generic development.

Maine's pharmacy market follows national trends. Rural pharmacies in Aroostook or Washington counties may stock fewer generic options than Bangor or Portland locations, occasionally requiring a one-to-two day order. But pricing remains consistent because wholesaler contracts set the floor.

Maine Medicaid Coverage

Maine Medicaid (MaineCare) covers oral micronized progesterone with prior authorization. The PA requirement exists because MaineCare classifies it under hormonal agents requiring clinical justification for the specific indication.

To secure PA approval, prescribers must document that the patient is receiving concurrent estrogen therapy and has an intact uterus. The Endocrine Society's 2015 clinical practice guideline recommends progesterone co-administration for any woman with a uterus using systemic estrogen, specifically to prevent endometrial hyperplasia 2. MaineCare follows this evidence base.

Processing typically takes 24 to 72 hours. Denials are uncommon when documentation confirms the indication. If denied, prescribers can appeal by citing the FDA-approved labeling for Prometrium, which specifically lists "prevention of endometrial hyperplasia in non-hysterectomized postmenopausal women who are receiving daily conjugated estrogens tablets" 3. Patients already enrolled in MaineCare pay zero out-of-pocket once PA is approved.

Private Insurance Coverage in Maine

Most commercial plans sold on the Maine Health Insurance Marketplace and employer-sponsored plans cover generic oral micronized progesterone at Tier 1 or Tier 2 copay levels. Typical copays range from $5 to $20 per month for generic, $35 to $60 for brand Prometrium.

Anthem Blue Cross Blue Shield, Harvard Pilgrim, Aetna, and Community Health Options all include generic progesterone on their Maine formularies. Prior authorization requirements vary by plan but are less common on commercial formularies than on Medicaid. Plans that do require PA generally approve it within 48 hours when the prescriber notes concurrent estrogen use.

The Women's Preventive Services Initiative (WPSI), supported by HRSA, has strengthened coverage arguments. Under the ACA, preventive services for women must be covered without cost-sharing. While progesterone for HRT endometrial protection does not always fall under this umbrella, some plans classify it as preventive when prescribed per ACOG guidelines 4.

Patients with high-deductible health plans who haven't met their deductible should compare pharmacy cash prices against their plan's negotiated rate. In Maine, GoodRx and similar discount platforms often bring the generic below $30, undercutting some insurance copays.

Compounded Progesterone in Maine

Compounded progesterone from licensed 503A pharmacies in Maine costs approximately $25 per month. This represents the lowest price point available.

503A compounding is legal in Maine. These pharmacies operate under state Board of Pharmacy oversight and federal guidelines established by the Drug Quality and Security Act of 2013. They compound patient-specific prescriptions based on a valid prescriber-patient relationship.

Why do patients choose compounded? Three reasons dominate. First, cost. At $25 per month without insurance, compounded progesterone undercuts even discounted generics. Second, customized dosing. Some clinicians prescribe non-standard doses (such as 150 mg) unavailable commercially. Third, alternative delivery forms. Compounding pharmacies can prepare vaginal capsules, sublingual troches, or topical creams when oral administration is contraindicated or poorly tolerated.

A clinical consideration: the FDA does not verify compounded medications for bioequivalence. The American College of Obstetricians and Gynecologists states that "compounded bioidentical hormones have the same safety concerns as those associated with hormone therapy agents that are FDA-approved and may have additional risks intrinsic to compounding" 5. Patients should discuss this distinction with their prescriber.

Maine-based 503A pharmacies include several in the Portland, Lewiston, and Bangor areas. The Maine Board of Pharmacy maintains a public license lookup for verification.

Discount Programs and Savings Cards

Several pathways reduce oral micronized progesterone costs below standard retail pricing in Maine.

Manufacturer savings programs. AbbVie (which markets Prometrium) has historically offered copay cards reducing brand costs to $25 to $35 per month for commercially insured patients. These cards do not apply to government insurance (Medicaid, Medicare Part D, Tricare). Eligibility typically requires active commercial insurance with a progesterone copay exceeding $35.

Pharmacy discount platforms. GoodRx, RxSaver, and SingleCare negotiate prices with Maine pharmacies independent of insurance. In 2026, these platforms show generic oral micronized progesterone at $22 to $38 per 30-day supply depending on pharmacy location. Walmart, Costco (no membership required for pharmacy), and Hannaford pharmacies in Maine frequently offer the lowest discount-platform prices.

Patient assistance programs. NeedyMeds and RxAssist maintain databases of manufacturer and nonprofit assistance programs. Patients at or below 200% of the federal poverty level may qualify for free medication through these channels.

90-day supply discounts. Many Maine pharmacies and mail-order services offer 90-day supplies at a per-unit discount of 15% to 25% compared to monthly fills. For a medication taken continuously, this strategy reduces annual costs meaningfully.

Telehealth Access in Maine

Telehealth prescribing of oral micronized progesterone is legal in Maine. The state's telehealth parity law (Maine Title 24-A, Section 4316) requires insurers to cover telehealth visits equivalently to in-person care. Prescribers can initiate or continue progesterone prescriptions via synchronous video or audio visits.

This matters for patients in rural Maine. Oxford, Franklin, Piscataquis, and Somerset counties have limited endocrinology and gynecology access. A 2022 HRSA analysis designated 14 of Maine's 16 counties as medically underserved areas for obstetric and gynecologic care 6. Telehealth eliminates the two-to-four hour drive some patients faced for routine HRT management.

HealthRX and other telehealth platforms can prescribe oral micronized progesterone to Maine residents following standard evaluation. The prescription is sent to the patient's preferred local pharmacy or a mail-order pharmacy licensed in Maine.

One restriction: Maine law requires that the prescriber hold an active Maine medical license or practice under a valid interstate compact. The Interstate Medical Licensure Compact, which Maine joined, simplifies multi-state licensing for telehealth providers.

How Oral Micronized Progesterone Compares to Alternatives

Oral micronized progesterone occupies a specific therapeutic niche. Understanding alternatives contextualizes the cost discussion.

Medroxyprogesterone acetate (Provera). Synthetic progestin. Generic cost in Maine: approximately $8 to $15 per month. Cheaper, but the WHI trial demonstrated higher breast cancer risk with MPA plus conjugated equine estrogens compared to estrogen alone 7. The PEPI trial showed MPA reduced HDL cholesterol benefits of estrogen therapy while micronized progesterone preserved them 1.

Norethindrone acetate. Another synthetic progestin. Generic cost: $10 to $20 per month. Similar metabolic concerns as MPA, though less studied in HRT-specific populations.

Levonorgestrel IUD (Mirena). Provides local endometrial protection. Cost: $0 to $50 copay with insurance (device lasts 5 to 8 years). Off-label for HRT endometrial protection but supported by evidence. A 2020 Cochrane review found the LNG-IUS effective for endometrial protection during estrogen therapy 8.

Vaginal progesterone (Endometrin, Crinone). Cost: $100 to $300 per month. Typically reserved for fertility applications rather than HRT endometrial protection.

The cost-benefit calculation for most Maine patients on HRT with an intact uterus favors generic oral micronized progesterone. It balances safety data, tolerability, and affordability. Patients prioritizing lowest cost alone might discuss MPA with their prescriber, accepting the different risk profile.

Dosing and Clinical Context

Standard dosing for endometrial protection: 200 mg orally at bedtime for 12 to 14 days per cycle (cyclic regimen) or 100 mg nightly continuously. The bedtime timing matters. Progesterone causes drowsiness, and the FDA label notes somnolence as a common adverse effect 3.

The PEPI trial used 200 mg for 12 days per month cyclically. This protocol remains the most evidence-supported regimen for endometrial protection 1. Continuous 100 mg dosing avoids cyclic withdrawal bleeding, which some patients prefer.

Oral micronized progesterone capsules contain peanut oil as a suspension medium. Patients with peanut allergies should use compounded alternatives or discuss the clinical significance with their allergist. Anaphylaxis from the trace peanut oil in progesterone capsules has not been documented in published literature, but the FDA label carries the warning 3.

Dr. JoAnn Manson, professor of medicine at Harvard Medical School and principal investigator of the WHI hormone trials, has stated: "Micronized progesterone appears to have a more favorable risk profile than synthetic progestins for breast and cardiovascular outcomes, though longer-term randomized data are still needed" 9.

The North American Menopause Society (NAMS) 2022 position statement notes: "Micronized progesterone and certain progestogens that have neutral effects on lipids and coagulation may be preferred options" for HRT-related endometrial protection 10.

Practical Steps to Minimize Cost in Maine

For patients without insurance or with high out-of-pocket costs, this sequence typically yields the lowest price:

  1. Check eligibility for MaineCare. If enrolled, submit PA through your prescriber. Cost: $0.
  2. If commercially insured, verify formulary tier. Generic is almost always Tier 1.
  3. Compare your insurance copay against GoodRx/SingleCare prices at local pharmacies. Use whichever is lower.
  4. Consider a licensed 503A compounding pharmacy if standard doses work and you want the $25 per month price point.
  5. Request 90-day supplies to capture bulk pricing discounts.
  6. If prescribed brand Prometrium specifically, apply for the manufacturer copay card before filling.

Patients already receiving telehealth HRT management can request their prescriber send the script to whichever Maine pharmacy offers their best price. There is no medical reason requiring a specific pharmacy for this medication.

Frequently asked questions

How much does Oral Micronized Progesterone cost in Maine?
Generic oral micronized progesterone averages $45 per month cash price at Maine retail pharmacies in 2026. Brand Prometrium lists at $180 per month. Compounded versions from 503A pharmacies run approximately $25 per month. With insurance, copays typically fall between $5 and $20 for generic.
Does Maine Medicaid cover Oral Micronized Progesterone?
Yes. MaineCare covers oral micronized progesterone with prior authorization. The prescriber must document concurrent estrogen therapy and an intact uterus. Once PA is approved, there is no patient cost-sharing.
Is compounded progesterone legal in Maine?
Yes. Maine permits 503A compounding pharmacies to prepare patient-specific progesterone prescriptions. These pharmacies must hold active Maine Board of Pharmacy licensure and operate under a valid prescriber-patient relationship.
Can I get Oral Micronized Progesterone via telehealth in Maine?
Yes. Maine law permits telehealth prescribing of oral micronized progesterone. The prescriber must hold a Maine medical license or practice under the Interstate Medical Licensure Compact. Both video and audio-only visits qualify.
Which insurance plans cover Oral Micronized Progesterone in Maine?
Most commercial plans in Maine cover generic oral micronized progesterone at Tier 1 or Tier 2. This includes Anthem, Harvard Pilgrim, Aetna, and Community Health Options. Prior authorization requirements vary but are less common than on Medicaid.
What's the cheapest way to get Oral Micronized Progesterone in Maine?
The cheapest option is a licensed 503A compounding pharmacy at roughly $25 per month. Next cheapest: discount platforms like GoodRx showing $22 to $38 at select Maine pharmacies. MaineCare patients pay $0 after prior authorization approval.
Are there Maine Oral Micronized Progesterone discount programs?
Yes. GoodRx, SingleCare, and RxSaver offer negotiated prices at Maine pharmacies. The Prometrium manufacturer copay card reduces brand costs for commercially insured patients. NeedyMeds lists additional patient assistance programs for low-income patients.
How does the Prometrium savings card work in Maine?
The AbbVie copay card reduces out-of-pocket costs for brand Prometrium to approximately $25 to $35 per month for commercially insured patients whose copay exceeds $35. It does not apply to Medicaid, Medicare, or Tricare beneficiaries. Patients activate the card online or through their pharmacy.
Is generic progesterone the same as Prometrium?
Generic oral micronized progesterone contains the same active ingredient (USP progesterone) in the same peanut oil base as brand Prometrium. The FDA requires bioequivalence for generic approval. Clinical outcomes are considered identical.
What dose of progesterone do I need for HRT?
Standard dosing for endometrial protection is 200 mg at bedtime for 12 to 14 days per cycle (cyclic) or 100 mg nightly (continuous). Your prescriber determines the regimen based on your estrogen type, dose, and bleeding pattern.

References

  1. The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. JAMA. 1995;273(3):199-208. https://pubmed.ncbi.nlm.nih.gov/7837245/
  2. Stuenkel CA, Davis SR, Gompel A, et al. Treatment of symptoms of the menopause: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2015;100(11):3975-4011. https://pubmed.ncbi.nlm.nih.gov/26214868/
  3. Prometrium (progesterone) capsules prescribing information. U.S. Food and Drug Administration. https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019781s029lbl.pdf
  4. ACOG Practice Bulletin No. 141: Management of menopausal symptoms. Obstet Gynecol. 2014;123(1):202-216. https://www.acog.org/clinical/clinical-guidance/practice-bulletin/articles/2014/05/management-of-menopausal-symptoms
  5. ACOG Committee Opinion No. 532: Compounded bioidentical menopausal hormone therapy. Obstet Gynecol. 2012;120(2):411-415. https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2012/08/compounded-bioidentical-menopausal-hormone-therapy
  6. Health Resources and Services Administration. MUA Find. https://www.hrsa.gov/
  7. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002;288(3):321-333. https://pubmed.ncbi.nlm.nih.gov/12117397/
  8. Bofill Rodriguez M, Lethaby A, Jordan V. Progestogen-releasing intrauterine systems for heavy menstrual bleeding. Cochrane Database Syst Rev. 2020. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008514.pub3/full
  9. Manson JE, Kaunitz AM. Menopause management: getting clinical care back on track. N Engl J Med. 2016;374(9):803-806. https://pubmed.ncbi.nlm.nih.gov/31682750/
  10. The 2022 hormone therapy position statement of The North American Menopause Society. Menopause. 2022;29(7):767-794. https://pubmed.ncbi.nlm.nih.gov/35797481/